Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thitiya Boonma"'
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 40:5283-5294
Hepatitis C virus (HCV) NS3/4A serine protease is a promising drug target for the discovery of anti-HCV drugs. However, its amino acid mutations, particularly A156T, commonly lead to rapid emergence of drug resistance. Paritaprevir and glecaprevir, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab1312f0057071afff2f5c37f966b82
https://doi.org/10.1080/07391102.2020.1869587
https://doi.org/10.1080/07391102.2020.1869587
Autor:
Thitiya Boonma, Nattharuja Soikudrua, Bodee Nutho, Thanyada Rungrotmongkol, Nadtanet Nunthaboot
Publikováno v:
Computational biology and chemistry. 101
Recently, the H3N2 influenza outbreak has caused serious global public health concern for future control of the next influenza pandemic. Since using current anti-influenza drugs targeting neuraminidase (oseltamivir and zanamivir) and the proton M2 ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd2e2a3105d068037fba2c58f81b861
https://pubmed.ncbi.nlm.nih.gov/36049355
https://pubmed.ncbi.nlm.nih.gov/36049355
Autor:
Thitiya Boonma, Bodee Nutho, Bunleu Sungthong, Nadtanet Nunthaboot, Thanyada Rungrotmongkol, Ployvadee Sripadung
Publikováno v:
Journal of Molecular Liquids. 344:117774
Atomistic molecular dynamics (MD) simulation of the inclusion complexes formation between scandenin, a phytochemical compound found in D. scandens, and five different types of cyclodextrin (CD); β-cyclodextrin (βCD), 2-hydroxypropyl βCD (2-HPβCD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95e67c1bb562f7fc190720147a74405d
https://doi.org/10.1016/j.molliq.2021.117774
https://doi.org/10.1016/j.molliq.2021.117774
Publikováno v:
Computational Biology and Chemistry. 83:107154
Hepatitis C virus (HCV) NS3/4A protease is an attractive target for the development of antiviral therapy. However, the evolution of antiviral drug resistance is a major problem for treatment of HCV infected patients. Understanding of drug-resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd5dbe2bf641ac145497356aba8b57a4
https://doi.org/10.1016/j.compbiolchem.2019.107154
https://doi.org/10.1016/j.compbiolchem.2019.107154